30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

NxStage Medical Inc (NXTM)

Track

Stock chart
Ticker: NXTM Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Swan Winifred L
SVP and General Counsel
1 sale — total 85,680 USD
Planned sale 20 Feb 2018
Value US$2,653,331.37 | Price 207.22 | Shares 13,090
Planned sale 16 Jan 2018
Value US$409,445.60 | Price 309.94 | Shares 10,132
Planned sale 20 Dec 2017
Value US$88,725.00 | Price 25.35 | Shares 3,500
Planned sale 15 Nov 2017
Value US$90,055.00 | Price 25.73 | Shares 3,500
Planned sale 20 Oct 2017
Value US$110,825.00 | Price 27.50 | Shares 4,030
Planned sale 20 Oct 2017
Value US$96,250.00 | Price 27.50 | Shares 3,500
Planned sale 4 Oct 2017
Value US$27,560.00 | Price 27.56 | Shares 1,000
Planned sale 20 Sep 2017
Value US$95,445.00 | Price 27.27 | Shares 3,500
Planned sale 20 Sep 2017
Value US$117,261.00 | Price 27.27 | Shares 4,300
Planned sale 5 Sep 2017
Value US$27,950.00 | Price 27.95 | Shares 1,000
Planned sale 21 Aug 2017
Value US$125,646.00 | Price 29.22 | Shares 4,300
Planned sale 15 Aug 2017
Value US$102,235.00 | Price 29.21 | Shares 3,500
Planned sale 10 Aug 2017
Value US$29,260.00 | Price 29.26 | Shares 1,000
Planned sale 7 Aug 2017
Value US$533,340.00 | Price 29.63 | Shares 18,000
Planned sale 7 Aug 2017
Value US$177,960.00 | Price 29.66 | Shares 6,000
Planned sale 3 Aug 2017
Value US$160,860.00 | Price 22.98 | Shares 7,000
Planned sale 20 Jul 2017
Value US$84,560.00 | Price 24.16 | Shares 3,500
Planned sale 20 Jul 2017
Value US$103,888.00 | Price 24.16 | Shares 4,300
Planned sale 5 Jul 2017
Value US$25,190.00 | Price 25.19 | Shares 1,000
Planned sale 20 Jun 2017
Value US$100,147.00 | Price 23.29 | Shares 4,300
Planned sale 15 Jun 2017
Value US$80,990.00 | Price 23.14 | Shares 3,500
Planned sale 14 Jun 2017
Value US$23,740.00 | Price 23.74 | Shares 1,000
Planned sale 8 Jun 2017
Value US$53,077.50 | Price 23.59 | Shares 2,250
Planned sale 22 May 2017
Value US$91,848.00 | Price 21.36 | Shares 4,300
Planned sale 15 May 2017
Value US$76,790.00 | Price 21.94 | Shares 3,500
Planned sale 10 May 2017
Value US$5,897.50 | Price 23.59 | Shares 250
Planned sale 3 May 2017
Value US$29,950.00 | Price 29.95 | Shares 1,000
Planned sale 20 Apr 2017
Value US$81,840.00 | Price 27.28 | Shares 3,000
Planned sale 20 Apr 2017
Value US$117,304.00 | Price 27.28 | Shares 4,300
Planned sale 20 Apr 2017
Value US$95,480.00 | Price 27.28 | Shares 3,500
Planned sale 19 Apr 2017
Value US$79,950.00 | Price 26.65 | Shares 3,000
Planned sale 13 Apr 2017
Value US$26,100.00 | Price 26.10 | Shares 1,000
Planned sale 3 Apr 2017
Value US$382,960.20 | Price 26.60 | Shares 14,397
Planned sale 22 Mar 2017
Value US$82,260.00 | Price 27.42 | Shares 3,000
Planned sale 21 Mar 2017
Value US$83,160.00 | Price 27.72 | Shares 3,000
Planned sale 20 Mar 2017
Value US$434,898.18 | Price 27.66 | Shares 15,723
Planned sale 20 Mar 2017
Value US$118,938.00 | Price 27.66 | Shares 4,300
Sale 16 Mar 2017
Value US$27,930.00 | Price 27.93 | Shares 1,000
Planned sale 8 Mar 2017
Value US$27,530.00 | Price 27.53 | Shares 1,000
Planned sale 7 Mar 2017
Value US$555,000.00 | Price 27.75 | Shares 20,000
Planned sale 6 Mar 2017
Value US$178,983.90 | Price 28.01 | Shares 6,390
Planned sale 23 Feb 2017
Value US$217,275.00 | Price 28.97 | Shares 7,500
Planned sale 22 Feb 2017
Value US$217,575.00 | Price 29.01 | Shares 7,500
Planned sale 21 Feb 2017
Value US$125,818.00 | Price 29.26 | Shares 4,300
Planned sale 17 Feb 2017
Value US$177,960.00 | Price 29.66 | Shares 6,000
Planned sale 15 Feb 2017
Value US$449,532.49 | Price 28.01 | Shares 16,049
Planned sale 14 Feb 2017
Value US$69,229.44 | Price 28.28 | Shares 2,448
Planned sale 10 Feb 2017
Value US$71,475.00 | Price 28.59 | Shares 2,500
Planned sale 9 Feb 2017
Value US$27,770.00 | Price 27.77 | Shares 1,000
Planned sale 8 Feb 2017
Value US$84,320.94 | Price 27.61 | Shares 3,054
Planned sale 7 Feb 2017
Value US$85,842.18 | Price 27.54 | Shares 3,117
Planned sale 6 Feb 2017
Value US$89,593.07 | Price 27.29 | Shares 3,283
Planned sale 3 Feb 2017
Value US$348,010.00 | Price 26.77 | Shares 13,000
Planned sale 2 Feb 2017
Value US$474,146.40 | Price 26.72 | Shares 17,745
Planned sale 2 Feb 2017
Value US$410,371.11 | Price 26.19 | Shares 15,669
Planned sale 1 Feb 2017
Value US$522,393.30 | Price 26.65 | Shares 19,602
Planned sale 26 Jan 2017
Value US$183,750.00 | Price 26.25 | Shares 7,000
Planned sale 25 Jan 2017
Value US$522,600.00 | Price 26.13 | Shares 20,000
Planned sale 24 Jan 2017
Value US$387,900.00 | Price 25.86 | Shares 15,000
Planned sale 23 Jan 2017
Value US$386,100.00 | Price 25.74 | Shares 15,000
Planned sale 20 Jan 2017
Value US$91,665.00 | Price 26.19 | Shares 3,500
Planned sale 20 Jan 2017
Value US$112,617.00 | Price 26.19 | Shares 4,300
Planned sale 19 Jan 2017
Value US$5,582.00 | Price 27.91 | Shares 200
Planned sale 19 Jan 2017
Value US$174,680.45 | Price 27.23 | Shares 6,415
Planned sale 18 Jan 2017
Value US$225,687.14 | Price 27.58 | Shares 8,183
Planned sale 18 Jan 2017
Value US$207,225.00 | Price 27.63 | Shares 7,500
Planned sale 17 Jan 2017
Value US$299,514.60 | Price 27.72 | Shares 10,805
Planned sale 17 Jan 2017
Value US$206,400.00 | Price 27.52 | Shares 7,500
Planned sale 13 Jan 2017
Value US$210,000.00 | Price 28.00 | Shares 7,500
Planned sale 11 Jan 2017
Value US$27,770.00 | Price 27.77 | Shares 1,000
Planned sale 20 Dec 2016
Value US$109,865.00 | Price 25.55 | Shares 4,300
Planned sale 15 Dec 2016
Value US$90,685.00 | Price 25.91 | Shares 3,500
Planned sale 14 Dec 2016
Value US$192,600.00 | Price 25.68 | Shares 7,500
Planned sale 13 Dec 2016
Value US$25,420.00 | Price 25.42 | Shares 1,000
Planned sale 13 Dec 2016
Value US$190,650.00 | Price 25.42 | Shares 7,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-02-22 2018-02-20 PlS Planned sale Swan Winifred L

SVP and General Counsel
13,090 -15.1%
207.22
US$2,653,331 		13,090 -15.1% 207.22 US$2,653,331
2018-01-19 2018-01-16 PlS Planned sale Swan Winifred L

SVP and General Counsel
10,132 -12.3%
309.94
US$409,446 		10,132 -12.3% 309.94 US$409,446
2017-12-21 2017-12-20 PlS Planned sale Swan Winifred L

SVP and General Counsel
63,496 +39.3%
140.86
US$589,225 		63,496 +39.3% 140.86 US$589,225
2017-11-15 2017-11-15 PlS Planned sale Swan Winifred L

SVP and General Counsel
3,500 -23.7%
25.73
US$90,055 		3,500 -23.7% 25.73 US$90,055
2017-10-23 2017-10-20 PlS Planned sale TOWSE MATTHEW W

SVP and Chief Financial Office
4,030 -14.2%
27.50
US$110,825 		4,030 -14.2% 27.50 US$110,825
2017-10-23 2017-10-20 PlS Planned sale Swan Winifred L

SVP and General Counsel
3,500 -22.9%
27.50
US$96,250 		3,500 -22.9% 27.50 US$96,250
2017-10-04 2017-10-04 PlS Planned sale Turk Joseph E Jr

President
1,000 -1.4%
27.56
US$27,560 		1,000 -1.4% 27.56 US$27,560
2017-09-21 2017-09-20 PlS Planned sale Swan Winifred L

SVP and General Counsel
3,500 -22.2%
27.27
US$95,445 		3,500 -22.2% 27.27 US$95,445
2017-09-21 2017-09-20 PlS Planned sale TOWSE MATTHEW W

SVP and Chief Financial Office
4,300 -15.0%
27.27
US$117,261 		4,300 -15.0% 27.27 US$117,261
2017-09-05 2017-09-05 PlS Planned sale Turk Joseph E Jr

President
1,000 -1.3%
27.95
US$27,950 		1,000 -1.3% 27.95 US$27,950
2017-08-23 2017-08-21 PlS Planned sale TOWSE MATTHEW W

SVP and Chief Financial Office
4,300 -15.0%
29.22
US$125,646 		4,300 -15.0% 29.22 US$125,646
2017-08-15 2017-08-15 PlS Planned sale Swan Winifred L

SVP and General Counsel
3,500 -21.5%
29.21
US$102,235 		3,500 -21.5% 29.21 US$102,235
2017-08-10 2017-08-10 PlS Planned sale Turk Joseph E Jr

President
1,000 -1.3%
29.26
US$29,260 		1,000 -1.3% 29.26 US$29,260
2017-08-08 2017-08-07 PlS Planned sale Turk Joseph E Jr

President
18,000 -19.2%
29.63
US$533,340 		18,000 -19.2% 29.63 US$533,340
2017-08-08 2017-08-07 PlS Planned sale Turk Joseph E Jr

President
6,000 -6.0%
29.66
US$177,960 		6,000 -6.0% 29.66 US$177,960
2017-08-04 2017-08-03 PlS Planned sale Turk Joseph E Jr

President
7,000 -8.4%
22.98
US$160,860 		7,000 -8.4% 22.98 US$160,860
2017-07-21 2017-07-20 PlS Planned sale Swan Winifred L

SVP and General Counsel
3,500 -20.9%
24.16
US$84,560 		3,500 -20.9% 24.16 US$84,560
2017-07-21 2017-07-20 PlS Planned sale TOWSE MATTHEW W

SVP and Chief Financial Office
4,300 -15.0%
24.16
US$103,888 		4,300 -15.0% 24.16 US$103,888
2017-07-07 2017-07-05 PlS Planned sale Turk Joseph E Jr

President
1,000 -1.3%
25.19
US$25,190 		1,000 -1.3% 25.19 US$25,190
2017-06-21 2017-06-20 PlS Planned sale TOWSE MATTHEW W

SVP and Chief Financial Office
4,300 -14.5%
23.29
US$100,147 		4,300 -14.5% 23.29 US$100,147
2017-06-16 2017-06-15 PlS Planned sale Swan Winifred L

SVP and General Counsel
3,500 -20.3%
23.14
US$80,990 		3,500 -20.3% 23.14 US$80,990
2017-07-07 2017-06-14 PlS Planned sale Turk Joseph E Jr

President
1,000 -1.3%
23.74
US$23,740 		1,000 -1.3% 23.74 US$23,740
2017-06-12 2017-06-08 PlS Planned sale Turk Joseph E Jr

President
2,250 -2.8%
23.59
US$53,078 		2,250 -2.8% 23.59 US$53,078
2017-05-23 2017-05-22 PlS Planned sale TOWSE MATTHEW W

SVP and Chief Financial Office
4,300 -14.5%
21.36
US$91,848 		4,300 -14.5% 21.36 US$91,848
2017-05-15 2017-05-15 PlS Planned sale Swan Winifred L

SVP and General Counsel
3,500 -19.7%
21.94
US$76,790 		3,500 -19.7% 21.94 US$76,790
2017-05-11 2017-05-10 PlS Planned sale Turk Joseph E Jr

President
250 -0.3%
23.59
US$5,898 		250 -0.3% 23.59 US$5,898
2017-05-04 2017-05-03 PlS Planned sale Turk Joseph E Jr

President
1,000 -1.3%
29.95
US$29,950 		1,000 -1.3% 29.95 US$29,950
2017-04-21 2017-04-20 PlS Planned sale Burbank Jeffrey H

Chief Executive Officer
3,000 -0.3%
27.28
US$81,840 		3,000 -0.3% 27.28 US$81,840
2017-04-20 2017-04-20 PlS Planned sale TOWSE MATTHEW W

SVP and Chief Financial Office
4,300 -14.5%
27.28
US$117,304 		4,300 -14.5% 27.28 US$117,304
2017-04-20 2017-04-20 PlS Planned sale Swan Winifred L

SVP and General Counsel
3,500 -19.2%
27.28
US$95,480 		3,500 -19.2% 27.28 US$95,480
2017-04-20 2017-04-19 PlS Planned sale Burbank Jeffrey H

Chief Executive Officer
3,000 -0.3%
26.65
US$79,950 		3,000 -0.3% 26.65 US$79,950
2017-04-14 2017-04-13 PlS Planned sale Turk Joseph E Jr

President
1,000 -1.3%
26.10
US$26,100 		1,000 -1.3% 26.10 US$26,100
2017-04-04 2017-04-03 PlS Planned sale Brown Robert S.

President, NxStage Kidney Care
14,397 -51.4%
26.60
US$382,960 		14,397 -51.4% 26.60 US$382,960
2017-03-23 2017-03-22 PlS Planned sale Burbank Jeffrey H

Chief Executive Officer
3,000 -0.3%
27.42
US$82,260 		3,000 -0.3% 27.42 US$82,260
2017-03-22 2017-03-21 PlS Planned sale Burbank Jeffrey H

Chief Executive Officer
3,000 -0.3%
27.72
US$83,160 		3,000 -0.3% 27.72 US$83,160
2017-03-22 2017-03-20 PlS Planned sale Swan Winifred L

SVP and General Counsel
15,723 -50.7%
27.66
US$434,898 		15,723 -50.7% 27.66 US$434,898
2017-03-22 2017-03-20 PlS Planned sale TOWSE MATTHEW W

SVP and Chief Financial Office
4,300 -14.5%
27.66
US$118,938 		4,300 -14.5% 27.66 US$118,938
2017-03-16 2017-03-16 S Sale MOORE CRAIG W
1,000 -1.0%
27.93
US$27,930 		1,000 -1.0% 27.93 US$27,930
2017-03-08 2017-03-08 PlS Planned sale Turk Joseph E Jr

President
1,000 -1.2%
27.53
US$27,530 		1,000 -1.2% 27.53 US$27,530
2017-03-07 2017-03-07 PlS Planned sale Brown Robert S.

President, NxStage Kidney Care
20,000 -55.4%
27.75
US$555,000 		20,000 -55.4% 27.75 US$555,000
2017-03-06 2017-03-06 PlS Planned sale Brown Robert S.

President, NxStage Kidney Care
6,390 -28.4%
28.01
US$178,984 		6,390 -28.4% 28.01 US$178,984
2017-02-24 2017-02-23 PlS Planned sale Burbank Jeffrey H

Chief Executive Officer
7,500 -0.8%
28.97
US$217,275 		7,500 -0.8% 28.97 US$217,275
2017-02-23 2017-02-22 PlS Planned sale Burbank Jeffrey H

Chief Executive Officer
7,500 -0.8%
29.01
US$217,575 		7,500 -0.8% 29.01 US$217,575
2017-02-23 2017-02-21 PlS Planned sale TOWSE MATTHEW W

SVP and Chief Financial Office
4,300 -18.7%
29.26
US$125,818 		4,300 -18.7% 29.26 US$125,818
2017-02-21 2017-02-17 PlS Planned sale Turk Joseph E Jr

President
6,000 -8.0%
29.66
US$177,960 		6,000 -8.0% 29.66 US$177,960
2017-02-15 2017-02-15 PlS Planned sale Swan Winifred L

SVP and General Counsel
16,049 -60.5%
28.01
US$449,532 		16,049 -60.5% 28.01 US$449,532
2017-02-15 2017-02-14 PlS Planned sale Brown Robert S.

President, NxStage Kidney Care
2,448 -12.4%
28.28
US$69,229 		2,448 -12.4% 28.28 US$69,229
2017-02-13 2017-02-10 PlS Planned sale Turk Joseph E Jr

President
2,500 -3.5%
28.59
US$71,475 		2,500 -3.5% 28.59 US$71,475
2017-02-13 2017-02-09 PlS Planned sale Turk Joseph E Jr

President
1,000 -1.4%
27.77
US$27,770 		1,000 -1.4% 27.77 US$27,770
2017-02-08 2017-02-08 PlS Planned sale Brown Robert S.

President, NxStage Kidney Care
3,054 -13.4%
27.61
US$84,321 		3,054 -13.4% 27.61 US$84,321
2017-02-07 2017-02-07 PlS Planned sale Brown Robert S.

President, NxStage Kidney Care
3,117 -12.0%
27.54
US$85,842 		3,117 -12.0% 27.54 US$85,842
2017-02-06 2017-02-06 PlS Planned sale Brown Robert S.

President, NxStage Kidney Care
3,283 -11.2%
27.29
US$89,593 		3,283 -11.2% 27.29 US$89,593
2017-02-06 2017-02-03 PlS Planned sale Brown Robert S.

President, NxStage Kidney Care
13,000 -30.8%
26.77
US$348,010 		13,000 -30.8% 26.77 US$348,010
2017-02-02 2017-02-02 PlS Planned sale Brown Robert S.

President, NxStage Kidney Care
17,745 -37.8%
26.72
US$474,146 		17,745 -37.8% 26.72 US$474,146
2017-02-02 2017-02-02 PlS Planned sale Turk Joseph E Jr

President
15,669 -18.2%
26.19
US$410,371 		15,669 -18.2% 26.19 US$410,371
2017-02-02 2017-02-01 PlS Planned sale Brown Robert S.

President, NxStage Kidney Care
19,602 -36.6%
26.65
US$522,393 		19,602 -36.6% 26.65 US$522,393
2017-01-26 2017-01-26 PlS Planned sale Brown Robert S.

President, NxStage Kidney Care
7,000 -14.7%
26.25
US$183,750 		7,000 -14.7% 26.25 US$183,750
2017-01-26 2017-01-25 PlS Planned sale Brown Robert S.

President, NxStage Kidney Care
20,000 -33.0%
26.13
US$522,600 		20,000 -33.0% 26.13 US$522,600
2017-01-26 2017-01-24 PlS Planned sale Brown Robert S.

President, NxStage Kidney Care
15,000 -27.0%
25.86
US$387,900 		15,000 -27.0% 25.86 US$387,900
2017-01-23 2017-01-23 PlS Planned sale Brown Robert S.

President, NxStage Kidney Care
15,000 -27.0%
25.74
US$386,100 		15,000 -27.0% 25.74 US$386,100
2017-01-23 2017-01-20 PlS Planned sale Swan Winifred L

SVP and General Counsel
3,500 -24.2%
26.19
US$91,665 		3,500 -24.2% 26.19 US$91,665
2017-01-23 2017-01-20 PlS Planned sale TOWSE MATTHEW W

SVP and Chief Financial Office
4,300 -18.7%
26.19
US$112,617 		4,300 -18.7% 26.19 US$112,617
2017-01-23 2017-01-19 PlS Planned sale Brown Robert S.

President, NxStage Kidney Care
200 -0.5%
27.91
US$5,582 		200 -0.5% 27.91 US$5,582
2017-01-23 2017-01-19 PlS Planned sale Brown Robert S.

President, NxStage Kidney Care
6,415 -13.6%
27.23
US$174,680 		6,415 -13.6% 27.23 US$174,680
2017-01-18 2017-01-18 PlS Planned sale Brown Robert S.

President, NxStage Kidney Care
8,183 -14.8%
27.58
US$225,687 		8,183 -14.8% 27.58 US$225,687
2017-01-18 2017-01-18 PlS Planned sale Burbank Jeffrey H

Chief Executive Officer
7,500 -0.9%
27.63
US$207,225 		7,500 -0.9% 27.63 US$207,225
2017-01-17 2017-01-17 PlS Planned sale Brown Robert S.

President, NxStage Kidney Care
10,805 -16.3%
27.72
US$299,515 		10,805 -16.3% 27.72 US$299,515
2017-01-17 2017-01-17 PlS Planned sale Burbank Jeffrey H

Chief Executive Officer
7,500 -0.8%
27.52
US$206,400 		7,500 -0.8% 27.52 US$206,400
2017-01-17 2017-01-13 PlS Planned sale Turk Joseph E Jr

President
7,500 -9.6%
28.00
US$210,000 		7,500 -9.6% 28.00 US$210,000
2017-01-11 2017-01-11 PlS Planned sale Turk Joseph E Jr

President
1,000 -1.3%
27.77
US$27,770 		1,000 -1.3% 27.77 US$27,770
2016-12-20 2016-12-20 PlS Planned sale TOWSE MATTHEW W

SVP and Chief Financial Office

Officer
4,300 -18.7%
25.55
US$109,865 		4,300 -18.7% 25.55 US$109,865
2016-12-16 2016-12-15 PlS Planned sale Swan Winifred L

SVP and General Counsel

Officer
3,500 -23.4%
25.91
US$90,685 		3,500 -23.4% 25.91 US$90,685
2016-12-14 2016-12-14 PlS Planned sale Burbank Jeffrey H

Chief Executive Officer

Executive Director
7,500 -0.8%
25.68
US$192,600 		7,500 -0.8% 25.68 US$192,600
2016-12-13 2016-12-13 PlS Planned sale Turk Joseph E Jr

President

Officer
1,000 -1.3%
25.42
US$25,420 		1,000 -1.3% 25.42 US$25,420
2016-12-13 2016-12-13 PlS Planned sale Burbank Jeffrey H

Chief Executive Officer

Executive Director
7,500 -0.8%
25.42
US$190,650 		7,500 -0.8% 25.42 US$190,650
Explore more

More insider trading research around NxStage Medical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America